NuShield® is a sterile and shelf-stable dehydrated placental allograft wound cover that retains all the layers of the placental membrane due to the novel LayerLoc™ preservation method.
• Novel LayerLoc™ preservation method retains all layers of the placental membrane that contain numerous growth factors and cytokines with angiogenic, regenerative, and anti-inflammatory properties
• Real-world evidence and in vitro studies demonstrate that NuShield® helps support healing in a variety of wound types and sizes
NuShield® is an allograft intended for use in the management of acute and chronic wounds as well as appropriate surgical applications. NuShield® may be applied as a wound covering to a variety of partial- and full-thickness acute and chronic wounds and wounds with exposed tendon, muscle, joint capsule and bone. NuShield® can be applied from the onset and for the duration of the wound, weekly or at the discretion of the health care practitioner.
NuShield® is contraindicated for use on clinically infected wounds.
NuShield® is contraindicated for surgical implantation sites with active or latent infection.
See IFU for additional information.
As with all allogeneic materials, it is not possible to provide an absolute guarantee that no infectious disease will be transmitted. However, this risk is greatly reduced by using processing treatments shown to be capable of reducing this risk as well as the use of strict donor screening criteria, laboratory testing, aseptic processing and terminal gamma irradiation of final product. Single patient, single use only. Do not sterilize or re-sterilize.
Transmission of diseases of unknown etiology; transmission of known infectious agents including, but not limited to, viruses, bacteria and fungi; immune rejection of implanted HCT/P; or loss of function and/or integrity of implanted HCT/P due to resorption, fragmentation and/or disintegration.
Store at ambient temperature.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers|
|Contact manufacturer for usage guidelines||●|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available||●|
Remove NuShield® from its sterile packaging using aseptic technique, being careful to maintain the sterility of the product. To determine which side of NuShield® is the chorion side (to be placed in contact with the wound bed), verify that the middle notch is at the top, and the notched corner is to its right, then the upper side is epithelial and the side facing down is chorion. Place NuShield® onto the wound bed, being careful to preserve orientation of the product and ensure that the chorion side is in contact with the wound bed. Once NuShield® is placed, the product may be rehydrated as necessary, based on the characteristics of the wound (NuShield® is easier to manipulate prior to rehydration).
A non-adherent, non-occlusive primary dressing may be used directly over NuShield®.
Organogenesis is a global leader in advanced wound care, offering a comprehensive portfolio of regenerative medicine products capable of supporting patients from early in the wound healing process through to wound closure, regardless of wound type.